Interpretation of the Key Issues of Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease.
作者信息
Sun Lina, Chen Yahong
机构信息
Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital; Research Center for Chronic Airway Diseases, Peking University Health Science Center, Beijing 100191, China.
出版信息
J Transl Int Med. 2023 Jan 13;10(4):277-280. doi: 10.2478/jtim-2022-0069. eCollection 2022 Dec.
Abstract
摘要
相似文献
1
Interpretation of the Key Issues of Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病免疫调节治疗专家共识关键问题解读
J Transl Int Med. 2023 Jan 13;10(4):277-280. doi: 10.2478/jtim-2022-0069. eCollection 2022 Dec.
2
Expert consensus on multi-disciplinary treatment, whole-course pulmonary rehabilitation management in patients with lung cancer and chronic obstructive lung disease.专家共识：肺癌和慢性阻塞性肺疾病患者的多学科治疗、全程肺康复管理。
Ann Palliat Med. 2022 May;11(5):1605-1623. doi: 10.21037/apm-22-549.
3
[Expert consensus on physician-pharmacist collaborative management of stable chronic obstructive pulmonary disease].[稳定期慢性阻塞性肺疾病医师-药师协作管理专家共识]
Zhonghua Jie He He Hu Xi Za Zhi. 2022 Oct 12;45(10):980-987. doi: 10.3760/cma.j.cn112147-20220413-00316.
4
Unmet need in the management of chronic obstructive pulmonary disease in the Middle East and Africa region: An expert panel consensus.中东和非洲地区慢性阻塞性肺疾病管理中的未满足需求：专家小组共识。
Respir Med. 2021 Nov-Dec;189:106641. doi: 10.1016/j.rmed.2021.106641. Epub 2021 Oct 5.
5
[Expert consensus of Chinese and Western medicine treatment on acute exacerbation of chronic obstructive pulmonary disease in China (2021)].《中国中西医结合治疗慢性阻塞性肺疾病急性加重专家共识（2021年版）》
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Nov;33(11):1281-1290. doi: 10.3760/cma.j.cn121430-20211003-01438.
6
"Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease": a consensus document.《慢性阻塞性肺疾病中吸入性糖皮质激素的正确使用》：一份共识文件
Arch Bronconeumol. 2015 Apr;51(4):193-8. doi: 10.1016/j.arbres.2014.11.001. Epub 2014 Dec 23.
7
[The optimal use of glucocorticoids for patients with chronic obstructive pulmonary disease: a Chinese expert consensus(2021)].《糖皮质激素在慢性阻塞性肺疾病患者中的优化应用：中国专家共识（2021年）》
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Dec 12;44(12):1054-1063. doi: 10.3760/cma.j.cn112147-20210802-00543.
8
[Background and thoughts on"The optimal use of glucocorticoids for patients with chronic obstructive pulmonary disease: a Chinese expert consensus (2021)"].["《慢性阻塞性肺疾病患者糖皮质激素的优化使用：中国专家共识（2021年）》的背景与思考"]
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Dec 12;44(12):1034-1036. doi: 10.3760/cma.j.cn112147-20210929-00686.
9
Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective.慢性阻塞性肺疾病全球倡议：慢性阻塞性肺疾病诊断、管理和预防策略——亚太视角
Respirology. 2005 Jan;10(1):9-17. doi: 10.1111/j.1440-1843.2005.00692.x.
10
Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China.中华人民共和国慢性阻塞性肺疾病急性加重专家共识。
Int J Chron Obstruct Pulmon Dis. 2014 Apr 25;9:381-95. doi: 10.2147/COPD.S58454. eCollection 2014.
引用本文的文献
1
Identification of key genes and regulatory networks involved in the Comorbidity of atrial fibrillation and chronic obstructive pulmonary disease.心房颤动与慢性阻塞性肺疾病共病相关关键基因及调控网络的鉴定
Heliyon. 2023 Nov 17;9(11):e22430. doi: 10.1016/j.heliyon.2023.e22430. eCollection 2023 Nov.
2
Astaxanthin attenuates cigarette smoke-induced small airway remodeling via the AKT1 signaling pathway.虾青素通过 AKT1 信号通路减轻香烟烟雾诱导的小气道重塑。
Respir Res. 2024 Mar 30;25(1):148. doi: 10.1186/s12931-024-02768-4.
3
HDAC6-selective inhibitor CAY10603 ameliorates cigarette smoke-induced small airway remodeling by regulating epithelial barrier dysfunction and reversing.HDAC6选择性抑制剂CAY10603通过调节上皮屏障功能障碍和逆转来改善香烟烟雾诱导的小气道重塑。
Respir Res. 2024 Feb 5;25(1):66. doi: 10.1186/s12931-024-02688-3.
4
Roles of noncoding RNAs in chronic obstructive pulmonary disease.非编码RNA在慢性阻塞性肺疾病中的作用。
J Transl Int Med. 2023 Jul 5;11(2):106-110. doi: 10.2478/jtim-2023-0084. eCollection 2023 Jun.
5
Blood eosinophils in chronic obstructive pulmonary disease: A potential biomarker.慢性阻塞性肺疾病中的血液嗜酸性粒细胞：一种潜在的生物标志物。
J Transl Int Med. 2023 Sep 2;11(3):193-197. doi: 10.2478/jtim-2023-0096. eCollection 2023 Sep.
6
Animal models: An essential tool to dissect the heterogeneity of chronic obstructive pulmonary disease.动物模型：剖析慢性阻塞性肺疾病异质性的重要工具。
J Transl Int Med. 2023 May 7;11(1):4-10. doi: 10.2478/jtim-2023-0007. eCollection 2023 Mar.
7
Standardized inhalation capability assessment: A key to optimal inhaler selection for inhalation therapy.标准化吸入能力评估：吸入疗法最佳吸入器选择的关键。
J Transl Int Med. 2023 Mar 7;11(1):26-29. doi: 10.2478/jtim-2022-0073. eCollection 2023 Mar.
本文引用的文献
1
A Meta-Analysis on the Efficacy and Safety of Bacterial Lysates in Chronic Obstructive Pulmonary Disease.细菌溶解产物治疗慢性阻塞性肺疾病疗效与安全性的Meta分析
Front Med (Lausanne). 2022 Jun 9;9:877124. doi: 10.3389/fmed.2022.877124. eCollection 2022.
2
Bacterial lysates (OM-85 BV): a cost-effective proposal in order to contrast antibiotic resistance.细菌裂解物（OM-85BV）：一种具有成本效益的对抗抗生素耐药性的方案。
J Prev Med Hyg. 2021 Jul 30;62(2):E564-E573. doi: 10.15167/2421-4248/jpmh2021.62.2.1734. eCollection 2021 Jun.
3
Efficacy of Low-Dose versus High-Dose Continuous Cyclic Azithromycin Therapy for Preventing Acute Exacerbations of COPD.小剂量与大剂量连续环丙沙星治疗预防 COPD 急性加重的疗效。
Respiration. 2021;100(11):1070-1077. doi: 10.1159/000517781. Epub 2021 Aug 6.
4
[Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2021)].慢性阻塞性肺疾病诊断和管理指南（2021年修订版）
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Mar 12;44(3):170-205. doi: 10.3760/cma.j.cn112147-20210109-00031.
5
Vitamin D and its therapeutic relevance in pulmonary diseases.维生素 D 及其在肺部疾病中的治疗相关性。
J Nutr Biochem. 2021 Apr;90:108571. doi: 10.1016/j.jnutbio.2020.108571. Epub 2020 Dec 31.
6
Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study.在 COPD 中新型吸入型 PDE4 抑制剂 CHF6001 的疗效和安全性：PIONEER 研究。
Respir Res. 2020 Sep 22;21(1):246. doi: 10.1186/s12931-020-01512-y.
7
COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition.COPD 痰液嗜酸性粒细胞：与血液嗜酸性粒细胞的关系及吸入 PDE4 抑制的作用。
Eur Respir J. 2020 Aug 6;56(2). doi: 10.1183/13993003.00237-2020. Print 2020 Aug.
8
Effect of acupoint application on T lymphocyte subsets in patients with chronic obstructive pulmonary disease: A meta-analysis.穴位贴敷对慢性阻塞性肺疾病患者T淋巴细胞亚群的影响：一项Meta分析。
Medicine (Baltimore). 2020 Apr;99(16):e19537. doi: 10.1097/MD.0000000000019537.
9
A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPD.一项评估吸入型双重磷酸二酯酶 3 和 4 抑制剂恩西司特林治疗 COPD 的剂量范围研究。
Respir Res. 2020 Feb 10;21(1):47. doi: 10.1186/s12931-020-1307-4.
10
Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial.阿奇霉素治疗需要住院的急性慢性阻塞性肺疾病恶化（BACE）。一项多中心、随机、双盲、安慰剂对照试验。
Am J Respir Crit Care Med. 2019 Oct 1;200(7):857-868. doi: 10.1164/rccm.201901-0094OC.
Zotero 插件